Xograph Healthcare sold to Healthcare 21 Group
Healthcare 21 Group, one of Northern Europe’s largest privately-owned healthcare companies, has completed the acquisition of Gloucestershire-based Xograph Healthcare, in a transaction advised by BCMS.
Established in 1967, Xograph is a leading independent medical imaging equipment supplier serving hospitals and diagnostic centres throughout the UK and Ireland. It operates through its product segments such as medical imaging, veterinary imaging, dental imaging and mammography. The company partners with Canon Medical, Ziehm Imaging, OrthoScan, Planmeca, Arcoma, NRT and Visbion.
Established in 2003, Healthcare 21 has operations across Ireland, UK, Germany and Austria. It is a leading provider of sales, marketing, customer service, engineering and technical services and logistics for a variety of market leading global MedTech manufacturers.
At the time of the transaction, which completed in late 2019, Xograph Managing Director, Paul Andrews, said: “What an exciting time this is. I am so proud to be leading Xograph Healthcare through one of the most dynamic periods in the Company’s 53-year history. As the newest member of the Healthcare 21 team, we can now realise new growth potential, share best practices with other HC21 business units and deliver customer service excellence with every interaction.”
Owen Curtin, chairman of Healthcare 21 Group, added: “The acquisition of Xograph Healthcare maintains our exciting programme of growth and expansion, accelerating our drive to become a pan European, best-in-class provider of specialist sales, marketing and technical service solutions for our world leading healthcare and scientific supplier partners. Acquiring Xograph confirms our commitment to the highly innovative MedTech and Diagnostic Technical services industry. The Xograph business, combined with our existing teams, now makes the Healthcare 21 Group one the largest players in the sector across the UK and Irish healthcare market.”
The newly combined business will employ up to 500 staff in the UK, Ireland, Germany and Austria, with a turnover in excess of £135m (€160m), representing more than a hundred Original Equipment Manufacturers (OEMs) across its four European markets.
BCMS Assistant Director Judith Robinson commented: “We are delighted with the result and pleased that BCMS identified strong interest in Xograph Healthcare. We found an acquirer with significant synergies, which means that the business will have a great opportunity to scale and continue to flourish going forward.”